Resource Library
Showing 41 to 50 of 211 results
To understand blood cancers, you need to know where the three types of cells in the blood come from and where they go: red blood cells, white blood cells and platelets.
Your treatment plan for DLBCL will be based on your age and overall health, potential long-term side effects, your stage (where the disease is located in you), symptoms, and fertility if applicable. Types of treatment for DLBCL include traditional chemotherapies, targeted therapies, stem cell transplant, radiation, and immunotherapies.
A type of non-Hodgkin lymphoma, diffuse large B-cell lymphoma (DLBCL) involves the B-cells that help to fight off infection, can grow quickly (aggressive) or slowly (indolent), can happen at any age but most often appears in middle age or older, and usually has no known cause.
Maintenance therapy is treatment given after the first (primary) therapy used to manage your cancer, or lower your risk of the cancer coming back. Some people may use maintenance therapy for a long time. This type of therapy can include drugs, vaccines, antibodies, or hormones.
Maintenance therapy can be used after a stem cell transplant for a blood…
Maintenance therapy can be used after a stem cell transplant for a blood…
“We’re hoping that when individuals living with illness, and their families, hear the term “palliative’ they shift their perspective from being afraid they’re coming to the end of life, and start to feel that palliative care is going to support their well-being and quality of life,” says Valerie Fiset, director of the Champlain Hospice Palliative Care…
“The majority of people with DLBCL will be cured with their first treatment – so that's a success story,” says Dr. John Kuruvilla, working as a hematologist-oncologist for 20 years including as a researcher in DLBCL, which is the largest form of non-Hodgkin lymphoma.
“Researchers are now focused on maintaining an excellent cure rate and…
“Researchers are now focused on maintaining an excellent cure rate and…
In this 1-hour presentation, Dr. Abi.Vijenthira, hematologist at Princess Margaret Cancer Centre in Toronto, provided an overview of the approach to non-Hodgkin lymphomas, and provided updates on recent developments in the management of these lymphomas.
In this 1-hour presentation, Dr. Mary-Margaret Keating, hematologist at the QEII Health Sciences Centre in Halifax, NS, provided an overview of the approach to Hodgkin lymphoma and updates on recent developments in the management of this lymphoma.
Both cancer and your treatment can cause side effects. A common side effect is damage to the cells that line the inside of your mouth and throat. This can lead to pain, sores, trouble swallowing, dry mouth, and infections.